Multiple Forms of Cardiac Myosin-binding Protein C Exist and Can Regulate Thick Filament Stability

od Kulikovskaya, Irina, McClellan, George B., Levine, Rhea, Winegrad, Saul
Izdano 2007

Multiple Forms of Cardiac Myosin-binding Protein C Exist and Can Regulate Thick Filament Stability

od Kulikovskaya, Irina, McClellan, George B., Levine, Rhea, Winegrad, Saul
Izdano 2009

Effect of MyBP-C Binding to Actin on Contractility in Heart Muscle

od Kulikovskaya, Irina, McClellan, George, Flavigny, Jeanne, Carrier, Lucie, Winegrad, Saul
Izdano 2003

uPA Impairs Cerebrovasodilation After Hypoxia/Ischemia Through LRP and ERK MAPK

od Armstead, William M., Cines, Douglas B., Bdeir, Khalil, Kulikovskaya, Irina, Stein, Sherman C., Higazi, Abd Al-Roof
Izdano 2008

Crystal structure of MTCP-1: Implications for role of TCL-1 and MTCP-1 in T cell malignancies

od Fu, Zheng-Qing, Du Bois, Garrett C., Song, Sherry P., Kulikovskaya, Irina, Virgilio, Laura, Rothstein, Jay L., Croce, Carlo M., Weber, Irene T., Harrison, Robert W.
Izdano 1998

T cells targeting NY-ESO-1 demonstrate efficacy against disseminated neuroblastoma

od Singh, Nathan, Kulikovskaya, Irina, Barrett, David M., Binder-Scholl, Gwendolyn, Jakobsen, Bent, Martinez, Daniel, Pawel, Bruce, June, Carl H., Kalos, Michael D., Grupp, Stephan A.
Izdano u Oncoimmunology (2015)

Neutrophil α-Defensins Cause Lung Injury by Disrupting the Capillary–Epithelial Barrier

od Bdeir, Khalil, Higazi, Abd Al-Roof, Kulikovskaya, Irina, Christofidou-Solomidou, Melpo, Vinogradov, Sergei A., Allen, Timothy C., Idell, Steven, Linzmeier, Rose, Ganz, Tomas, Cines, Douglas B.
Izdano 2010

Retroviral and Lentiviral Safety Analysis of Gene-Modified T Cell Products and Infused HIV and Oncology Patients

od Marcucci, Katherine T., Jadlowsky, Julie K., Hwang, Wei-Ting, Suhoski-Davis, Megan, Gonzalez, Vanessa E., Kulikovskaya, Irina, Gupta, Minnal, Lacey, Simon F., Plesa, Gabriela, Chew, Anne, Melenhorst, J. Joseph, Levine, Bruce L., June, Carl H.
Izdano u Mol Ther (2018)

Autologous CD4 T Lymphocytes Modified with a Tat-Dependent, Virus-Specific Endoribonuclease Gene in HIV-Infected Individuals

od Jacobson, Jeffrey M., Jadlowsky, Julie K., Lacey, Simon F., Fraietta, Joseph A., Plesa, Gabriela, Chono, Hideto, Lee, Dong H., Kulikovskaya, Irina, Bartoszek, Chelsie, Chen, Fang, Tian, Lifeng, Dimitri, Alexander, Levine, Bruce L., Veloso, Elizabeth A., Hwang, Wei-Ting, June, Carl H.
Izdano u Mol Ther (2021)

Activity of Mesothelin-specific Chimeric Antigen Receptor T cells Against Pancreatic Carcinoma Metastases in a Phase 1 Trial

od Beatty, Gregory L., O’Hara, Mark H., Lacey, Simon F., Torigian, Drew A., Nazimuddin, Farzana, Chen, Fang, Kulikovskaya, Irina M., Soulen, Michael C., McGarvey, Maureen, Nelson, Anne Marie, Gladney, Whitney L., Levine, Bruce L., Melenhorst, J. Joseph, Plesa, Gabriela, June, Carl H.
Izdano u Gastroenterology (2018)

Supraphysiologic control over HIV-1 replication mediated by CD8 T cells expressing a re-engineered CD4-based chimeric antigen receptor

od Leibman, Rachel S., Richardson, Max W., Ellebrecht, Christoph T., Maldini, Colby R., Glover, Joshua A., Secreto, Anthony J., Kulikovskaya, Irina, Lacey, Simon F., Akkina, Sarah R., Yi, Yanjie, Shaheen, Farida, Wang, Jianbin, Dufendach, Keith A., Holmes, Michael C., Collman, Ronald G., Payne, Aimee S., Riley, James L.
Izdano u PLoS Pathog (2017)

Adoptive immunotherapy with engineered T cells expressing and HLA-A2 restricted affinity-enhanced TCR for LAGE-1 and NY-ESO-1 in patients with multiple myeloma following auto-SCT

od Rapoport, Aaron P, Stadtmauer, Edward A, Vogl, Dan T, Weiss, Brendan, Binder-Scholl, Gwendolyn K, Smethurst, Dominic P, Finklestein, Jeffrey, Kulikovskaya, Irina, Gupta, Minnal, Brewer, Joanna E, Bennett, Alan D, Gerry, Andrew B, Pumphrey, Nick J, Tayton-Martin, Helen K, Ribeiro, Lilliam, Badros, Ashraf Z, Yanovich, Saul, Akpek, Gorgun, Kerr, Naseem, Philip, Sunita, Westphal, Sandra, Bruce, Levine L, Jakobsen, Bent K, June, Carl H, Kalos, Michael
Izdano 2013

Safety and efficacy of intratumoral injections of chimeric antigen receptor (CAR) T cells in metastatic breast cancer

od Tchou, Julia, Zhao, Yangbing, Levine, Bruce L, Zhang, Paul J, Davis, Megan M, Melenhorst, Jan Joseph, Kulikovskaya, Irina, Brennan, Andrea L, Liu, Xiaojun, Lacey, Simon F, Posey, Avery, Williams, Austin D, So, Alycia, Conejo-Garcia, Jose R, Plesa, Gabriela, Young, Regina M., McGettigan, Shannon, Campbell, Jean, Pierce, Robert H, Matro, Jennifer M, DeMichele, Angela M, Clark, Amy S, Cooper, Laurence J, Schuchter, Lynn M., Vonderheide, Robert H, June, Carl H
Izdano u Cancer Immunol Res (2017)

Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell

od Ruella, Marco, Xu, Jun, Barrett, David M., Fraietta, Joseph A., Reich, Tyler J., Ambrose, David E., Klichinsky, Michael, Shestova, Olga, Patel, Prachi R., Kulikovskaya, Irina, Nazimuddin, Farzana, Bhoj, Vijay G., Orlando, Elena J., Fry, Terry J., Bitter, Hans, Maude, Shannon L., Levine, Bruce L., Nobles, Christopher L., Bushman, Frederic D., Young, Regina M., Scholler, John, Gill, Saar I., June, Carl H., Grupp, Stephan A., Lacey, Simon F., Melenhorst, J. Joseph
Izdano u Nat Med (2018)

Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma

od Garfall, Alfred L., Stadtmauer, Edward A., Hwang, Wei-Ting, Lacey, Simon F., Melenhorst, Jan Joseph, Krevvata, Maria, Carroll, Martin P., Matsui, William H., Wang, Qiuju, Dhodapkar, Madhav V., Dhodapkar, Kavita, Das, Rituparna, Vogl, Dan T., Weiss, Brendan M., Cohen, Adam D., Mangan, Patricia A., Ayers, Emily C., Nunez-Cruz, Selene, Kulikovskaya, Irina, Davis, Megan M., Lamontagne, Anne, Dengel, Karen, Kerr, Naseem D.S., Young, Regina M., Siegel, Donald L., Levine, Bruce L., Milone, Michael C., Maus, Marcela V., June, Carl H.
Izdano u JCI Insight (2018)

Identification of a Titin-Derived HLA-A1–Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3–Directed T Cells

od Cameron, Brian J., Gerry, Andrew B., Dukes, Joseph, Harper, Jane V., Kannan, Vivekanandan, Bianchi, Frayne C., Grand, Francis, Brewer, Joanna E., Gupta, Minnal, Plesa, Gabriela, Bossi, Giovanna, Vuidepot, Annelise, Powlesland, Alex S., Legg, Alison, Adams, Katherine J., Bennett, Alan D., Pumphrey, Nicholas J., Williams, Daniel D., Binder-Scholl, Gwendolyn, Kulikovskaya, Irina, Levine, Bruce L., Riley, James L., Varela-Rohena, Angel, Stadtmauer, Edward A., Rapoport, Aaron P., Linette, Gerald P., June, Carl H., Hassan, Namir J., Kalos, Michael, Jakobsen, Bent K.
Izdano u Sci Transl Med (2013)

Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma

od Garfall, Alfred L., Stadtmauer, Edward A., Hwang, Wei-Ting, Lacey, Simon F., Melenhorst, Jan Joseph, Krevvata, Maria, Carroll, Martin P., Matsui, William H., Wang, Qiuju, Dhodapkar, Madhav V., Dhodapkar, Kavita, Das, Rituparna, Vogl, Dan T., Weiss, Brendan M., Cohen, Adam D., Mangan, Patricia A., Ayers, Emily C., Nunez-Cruz, Selene, Kulikovskaya, Irina, Davis, Megan M., Lamontagne, Anne, Dengel, Karen, Kerr, Naseem D.S., Young, Regina M., Siegel, Donald L., Levine, Bruce L., Milone, Michael C., Maus, Marcela V., June, Carl H.
Izdano u JCI Insight (2019)

NY-ESO-1 specific TCR engineered T-cells mediate sustained antigen-specific antitumor effects in myeloma

od Rapoport, Aaron P., Stadtmauer, Edward A., Binder-Scholl, Gwendolyn K., Goloubeva, Olga, Vogl, Dan T., Lacey, Simon F., Badros, Ashraf Z., Garfall, Alfred, Weiss, Brendan, Finklestein, Jeffrey, Kulikovskaya, Irina, Sinha, Sanjoy K., Kronsberg, Shari, Gupta, Minnal, Bond, Sarah, Melchiori, Luca, Brewer, Joanna E., Bennett, Alan D., Gerry, Andrew B., Pumphrey, Nicholas J., Williams, Daniel, Tayton-Martin, Helen K., Ribeiro, Lilliam, Holdich, Tom, Yanovich, Saul, Hardy, Nancy, Yared, Jean, Kerr, Naseem, Philip, Sunita, Westphal, Sandra, Siegel, Don L., Levine, Bruce L., Jakobsen, Bent K., Kalos, Michael, June, Carl H.
Izdano u Nat Med (2015)

Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia

od Fraietta, Joseph A., Lacey, Simon F., Orlando, Elena J., Pruteanu-Malinici, Iulian, Gohil, Mercy, Lundh, Stefan, Boesteanu, Alina C., Wang, Yan, O’Connor, Roddy S., Hwang, Wei-Ting, Pequignot, Edward, Ambrose, David E., Zhang, Changfeng, Wilcox, Nicholas, Bedoya, Felipe, Dorfmeier, Corin, Chen, Fang, Tian, Lifeng, Parakandi, Harit, Gupta, Minnal, Young, Regina M., Johnson, F. Brad, Kulikovskaya, Irina, Liu, Li, Xu, Jun, Kassim, Sadik H., Davis, Megan M., Levine, Bruce L., Frey, Noelle V., Siegel, Donald L., Huang, Alexander C., Wherry, E. John, Bitter, Hans, Brogdon, Jennifer L., Porter, David L., June, Carl H., Melenhorst, J. Joseph
Izdano u Nat Med (2018)

Disruption of TET2 Promotes the Therapeutic Efficacy of CD19-targeted T-cells

od Fraietta, Joseph A., Nobles, Christopher L., Sammons, Morgan A., Lundh, Stefan, Carty, Shannon A., Reich, Tyler, Cogdill, Alexandria P., Morrissette, Jennifer J.D., DeNizio, Jamie E., Reddy, Shantan, Hwang, Young, Gohil, Mercy, Kulikovskaya, Irina, Nazimuddin, Farzana, Gupta, Minnal, Chen, Fang, Everett, John K., Alexander, Katherine A., Lin-Shiao, Enrique, Gee, Marvin H., Liu, Xiaojun, Young, Regina M., Ambrose, David, Wang, Yan, Xu, Jun, Jordan, Martha S., Marcucci, Katherine T., Levine, Bruce L., Garcia, K. Christopher, Zhao, Yangbing, Kalos, Michael, Porter, David L., Kohli, Rahul M., Lacey, Simon F., Berger, Shelley L., Bushman, Frederic D., June, Carl H., Melenhorst, J. Joseph
Izdano u Nature (2018)